Nestor Luque
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nestor Luque has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
- Miquel Ferrer
CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain; Department of Pneumology, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
10 shared publications - Antoni Torres
Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, 08036 Barcelona, Spain
9 shared publications Antoni Torres
Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), Ciber de Enfermedades Respiratorias (Ciberes), Barcelona, Spain
8 shared publicationsGianluigi Li Bassi
Division of Animal Experimentation, Department of Pulmonary and Critical Care Medicine, Thorax Institute, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomedica En Red-Enfermedades Respiratorias (CIBERES), Barcelona, Spain
8 shared publicationsMariano Esperatti
Hosp Clin Barcelona, Dept Pulm & Crit Care Med, Div Anim Expt, Thorax Inst, Barcelona, Spain
8 shared publicationsMontserrat Rigol
Division of Animal Experimentation, Department of Pulmonary and Critical Care Medicine, Thorax Institute, Hospital Clínic, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomedica En Red-Enfermedades Respiratorias (CIBERES), Barcelona, Spain
7 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Dirección General de Medicamentos, Insumos y Drogas (DIGEMID), Ministerio de Salud (Perú) in REVISTA CIENCIA, POLÍTICA Y REGULACIÓN FARMACÉUTICA
- Vol. 3 (1) , 30-38
Hospitales virtuales y cirugía robótica: una prospectiva de la transformación del sistema de salud hacia el 2050
Este estudio examina cómo los hospitales virtuales (HV) y la cirugía robótica influyen en la transformación del sistema de salud peruano con miras al 2050, basándose en información del Observatorio Peruano de Prospectiva. Los resultados muestran que la consolidación de los HV y la expansión de la cirugía robótica representan cambios significativos a nivel organizativo, tecnológico y social que contribuirán a mejorar el acceso a servicios, reducir hospitalizaciones, optimizar costos y a fortalecer el seguimiento de pacientes con enfermedades crónicas, especialmente en zonas con escasa disponibilidad de especialistas; sin embargo, persisten desafíos de conectividad, interoperabilidad, alfabetización digital y gestión de datos. Se proyecta un modelo híbrido sustentado en plataformas digitales integradas, atención predictiva y cirugía robótica a distancia para el 2050, que dependerá de decisiones estratégicas en materia de regulación, financiación y formación del talento humano, cuya sostenibilidad exige políticas públicas sólidas, fortalecimiento institucional y desarrollo continuo de capacidades digitales.
- 30 March 2026
- Published by Dirección General de Medicamentos, Insumos y Drogas (DIGEMID), Ministerio de Salud (Perú) in REVISTA CIENCIA, POLÍTICA Y REGULACIÓN FARMACÉUTICA
- Vol. 3 (1) , 30-38
Open AccessHospitales virtuales y cirugía robótica: una prospectiva de la transformación del sistema de salud hacia el 2050
Este estudio examina cómo los hospitales virtuales (HV) y la cirugía robótica influyen en la transformación del sistema de salud peruano con miras al 2050, basándose en información del Observatorio Peruano de Prospectiva. Los resultados muestran que la consolidación de los HV y la expansión de la cirugía robótica representan cambios significativos a nivel organizativo, tecnológico y social que contribuirán a mejorar el acceso a servicios, reducir hospitalizaciones, optimizar costos y a fortalecer el seguimiento de pacientes con enfermedades crónicas, especialmente en zonas con escasa disponibilidad de especialistas; sin embargo, persisten desafíos de conectividad, interoperabilidad, alfabetización digital y gestión de datos. Se proyecta un modelo híbrido sustentado en plataformas digitales integradas, atención predictiva y cirugía robótica a distancia para el 2050, que dependerá de decisiones estratégicas en materia de regulación, financiación y formación del talento humano, cuya sostenibilidad exige políticas públicas sólidas, fortalecimiento institucional y desarrollo continuo de capacidades digitales.
- Open Access
- 27 December 2025
- Published by Universidad Cientifica del Sur in South Health
- Vol. 2
Nuevas perspectivas en la neumonía adquirida en la comunidad en el adulto
La neumonía adquirida en la comunidad (NAC) continúa siendo una enfermedad con un gran impacto en la salud global, que afecta de manera particular a poblaciones vulnerables, como ancianos, individuos inmunodeprimidos, personas con enfermedades crónicas y niños pequeños. La epidemiología de la NAC está cambiando, evidenciándose un aumento en la proporción de pacientes inmunodeprimidos y adultos mayores hospitalizados por neumonía. Aunque la NAC es un problema universal, su distribución geográfica desigual y su predominio en países de media y baja renta demuestra las enormes inequidades que determinan su carga global. La mortalidad del paciente con NAC grave sigue siendo una preocupación importante, a pesar de los avances en el diagnóstico, nuevas opciones de tratamiento y terapias adyuvantes y otras medidas preventivas. Los principales desafíos relacionados con la NAC se relacionan con la identificación temprana de la neumonía, especialmente en poblaciones en mayor riesgo de una enfermedad grave, y con el inicio temprano y adecuado de tratamiento antimicrobiano, aspecto fundamental para lograr la mejor evolución clínica, especialmente en pacientes críticamente enfermos. Este escenario resalta la necesidad de mantenerse actualizado sobre los datos epidemiológicos y etiológicos, así como sobre las estrategias más eficaces para el manejo integral de esta enfermedad
- 27 December 2025
- Published by Universidad Cientifica del Sur in South Health
- Vol. 2
Open AccessNuevas perspectivas en la neumonía adquirida en la comunidad en el adulto
La neumonía adquirida en la comunidad (NAC) continúa siendo una enfermedad con un gran impacto en la salud global, que afecta de manera particular a poblaciones vulnerables, como ancianos, individuos inmunodeprimidos, personas con enfermedades crónicas y niños pequeños. La epidemiología de la NAC está cambiando, evidenciándose un aumento en la proporción de pacientes inmunodeprimidos y adultos mayores hospitalizados por neumonía. Aunque la NAC es un problema universal, su distribución geográfica desigual y su predominio en países de media y baja renta demuestra las enormes inequidades que determinan su carga global. La mortalidad del paciente con NAC grave sigue siendo una preocupación importante, a pesar de los avances en el diagnóstico, nuevas opciones de tratamiento y terapias adyuvantes y otras medidas preventivas. Los principales desafíos relacionados con la NAC se relacionan con la identificación temprana de la neumonía, especialmente en poblaciones en mayor riesgo de una enfermedad grave, y con el inicio temprano y adecuado de tratamiento antimicrobiano, aspecto fundamental para lograr la mejor evolución clínica, especialmente en pacientes críticamente enfermos. Este escenario resalta la necesidad de mantenerse actualizado sobre los datos epidemiológicos y etiológicos, así como sobre las estrategias más eficaces para el manejo integral de esta enfermedad
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2025 (1)
bla OXA−51 ‐Negative Acinetobacter calcoaceticus–baumannii Complex as a Cause of Human Infection in Peru
Background: Common identification techniques do not differentiate among members of the Acinetobacter calcoaceticus–baumannii (ACB) complex, and the presence of non‐ baumannii Acinetobacter is often misinterpreted. The b l a OXA−51 gene is located within the chromosome of Acinetobacter baumannii . Despite its plasmid dissemination to other members of the genus, it may be considered in initial species screening. Thus, this study aimed to determine the presence of b l a OXA−51 ‐negative Acinetobacter spp. as a cause of infection in Peru. Methods: Two hundred ninety‐eight ACB complex isolates from different regions of Peru were isolated between January 2018 and March 2024. Of these, 272 and 25 were confirmed as hospital‐acquired and community infections, respectively. The presence of b l a OXA−51 was determined by polymerase chain reaction, and the susceptibility levels to 12 antimicrobial agents were determined. Results: The results showed that 38 (12.7%) isolates were b l a OXA−51 ‐negative. These isolates were frequent among community infections (13/25, p < 0.0001), often causing urine infections. They showed significantly lower levels of resistance to almost all antimicrobial agents tested, and most of them were recovered from regions outside metropolitan Lima. Conclusion: A relevant number of infections by non‐ baumannii Acinetobacter species in Peru is suggested, highlighting the need for systematic identification of these species in the country.
- 1 January 2025
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2025 (1)
Open Accessbla OXA−51 ‐Negative Acinetobacter calcoaceticus–baumannii Complex as a Cause of Human Infection in Peru
Background: Common identification techniques do not differentiate among members of the Acinetobacter calcoaceticus–baumannii (ACB) complex, and the presence of non‐ baumannii Acinetobacter is often misinterpreted. The b l a OXA−51 gene is located within the chromosome of Acinetobacter baumannii . Despite its plasmid dissemination to other members of the genus, it may be considered in initial species screening. Thus, this study aimed to determine the presence of b l a OXA−51 ‐negative Acinetobacter spp. as a cause of infection in Peru. Methods: Two hundred ninety‐eight ACB complex isolates from different regions of Peru were isolated between January 2018 and March 2024. Of these, 272 and 25 were confirmed as hospital‐acquired and community infections, respectively. The presence of b l a OXA−51 was determined by polymerase chain reaction, and the susceptibility levels to 12 antimicrobial agents were determined. Results: The results showed that 38 (12.7%) isolates were b l a OXA−51 ‐negative. These isolates were frequent among community infections (13/25, p < 0.0001), often causing urine infections. They showed significantly lower levels of resistance to almost all antimicrobial agents tested, and most of them were recovered from regions outside metropolitan Lima. Conclusion: A relevant number of infections by non‐ baumannii Acinetobacter species in Peru is suggested, highlighting the need for systematic identification of these species in the country.
- Open Access
- 21 June 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (2) , 140-5
Detection of SARS-CoV-2 variants in hospital wastewater in Peru, 2022
Objetive. To identify the presence of the SARS-CoV-2 virus in wastewater from hospitals in Peru. Materials and methods. Water samples were collected from the effluents of nine hospitals in Peru during March and September 2022. SARS-CoV-2 was identified by using Illumina sequencing. Variant, lineage and clade assignments were carried out using the Illumina and Nextclado tools. We verified whether the SARS-CoV-2 variants obtained from wastewater were similar to those reported by the National Institute of Health of Peru from patients during the same period and region. Results. Eighteen of the 20 hospital wastewater samples (90%) provided sequences of sufficient quality to be classified as the Omicron variant according to the WHO classification. Among them, six (30%) were assigned by Nextclade to clades 21K lineage BA.1.1 (n=1), 21L lineage BA.2 (n=2), and 22B lineages BA.5.1 (n=2) and BA .5.5 (n=1). Conclusions. SARS-CoV-2 variants were found in hospital wastewater samples and were similar to those reported by the surveillance system in patients during the same weeks and geographic areas. Wastewater monitoring could provide information on the environmental and temporal variation of viruses such as SARS-CoV-2.
- 21 June 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (2) , 140-5
Open AccessDetection of SARS-CoV-2 variants in hospital wastewater in Peru, 2022
Objetive. To identify the presence of the SARS-CoV-2 virus in wastewater from hospitals in Peru. Materials and methods. Water samples were collected from the effluents of nine hospitals in Peru during March and September 2022. SARS-CoV-2 was identified by using Illumina sequencing. Variant, lineage and clade assignments were carried out using the Illumina and Nextclado tools. We verified whether the SARS-CoV-2 variants obtained from wastewater were similar to those reported by the National Institute of Health of Peru from patients during the same period and region. Results. Eighteen of the 20 hospital wastewater samples (90%) provided sequences of sufficient quality to be classified as the Omicron variant according to the WHO classification. Among them, six (30%) were assigned by Nextclade to clades 21K lineage BA.1.1 (n=1), 21L lineage BA.2 (n=2), and 22B lineages BA.5.1 (n=2) and BA .5.5 (n=1). Conclusions. SARS-CoV-2 variants were found in hospital wastewater samples and were similar to those reported by the surveillance system in patients during the same weeks and geographic areas. Wastewater monitoring could provide information on the environmental and temporal variation of viruses such as SARS-CoV-2.
- Open Access
- 31 March 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (1) , 67-72
Características clínicas y epidemiológicas de las muertes por dengue durante un brote en el norte del Perú
Con el objetivo de describir las características clínicas y epidemiológicas de los pacientes fallecidos por dengue durante el 2017 en Piura, se realizó un estudio retrospectivo de revisión de 24 historias clínicas. El 67% de los casos fueron mujeres y tres (12,5%) estaban embarazadas. La diabetes (12,5%) y la hipertensión (16,7%) fueron las comorbilidades más frecuentes. Sólo en el 12,5% se reportó dengue previo.El tiempo transcurrido desde asistencia sanitaria hasta la muerte fue de 4,10 (DE: 5,34) días. Se hicieron transfusiones de glóbulos rojos en el 45,8% de los casos, plasma en el 25%, plaquetas en el 16,8% ycrioprecipitado en el 16,8%. También fueron frecuentes la terapia con ristaloides (91,7%) y el tratamiento con fármacos vasoactivos (70,8%). En conclusión, la mortalidad del dengue grave fue mayoritaria en las mujeres adultas y el tiempo de atención desde el primer establecimiento de salud hasta una unidad especializada fue prolongada.
- 31 March 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (1) , 67-72
Open AccessCaracterísticas clínicas y epidemiológicas de las muertes por dengue durante un brote en el norte del Perú
Con el objetivo de describir las características clínicas y epidemiológicas de los pacientes fallecidos por dengue durante el 2017 en Piura, se realizó un estudio retrospectivo de revisión de 24 historias clínicas. El 67% de los casos fueron mujeres y tres (12,5%) estaban embarazadas. La diabetes (12,5%) y la hipertensión (16,7%) fueron las comorbilidades más frecuentes. Sólo en el 12,5% se reportó dengue previo.El tiempo transcurrido desde asistencia sanitaria hasta la muerte fue de 4,10 (DE: 5,34) días. Se hicieron transfusiones de glóbulos rojos en el 45,8% de los casos, plasma en el 25%, plaquetas en el 16,8% ycrioprecipitado en el 16,8%. También fueron frecuentes la terapia con ristaloides (91,7%) y el tratamiento con fármacos vasoactivos (70,8%). En conclusión, la mortalidad del dengue grave fue mayoritaria en las mujeres adultas y el tiempo de atención desde el primer establecimiento de salud hasta una unidad especializada fue prolongada.
- Open Access
- 4 October 2022
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 51 (3) , 197-212
Evolution of the prevalence and antimicrobial resistance among Escherichia coli isolated as a cause of infection in patients admitted to a iv-level hospital in Lima, Peru
The levels and evolution of antimicrobial resistance of Escherichia coli during 01/2009-06/2010 (Period 1), 01/2012-06-2013 (Period 2) and 07/2013-12/2014 (Period 3) were analyzed. Identification, susceptibility levels to 13 antibiotics and the presence of extendedspectrum β-lactamases (ESBLs) were determined. Overall, 9,918 microorganisms were isolated as a cause of infection. Of these 3,016 (30.4%) were E. coli, with 1,770 (59%), 992 (33%) and 254 (8%), from the Medicine and the Surgery Departments and the Intensive Care Unit (ICU), respectively. There was a significant increase (p=0.0002) of E. coli throughout considered periods. The isolates presented high levels of resistance (>60%) to cephalosporins, ciprofloxacin and cotrimoxazole, being only susceptible to imipenem (0.3% of resistance) and tigecycline. Overall the analysis of evolution of antimicrobial resistance showed that resistance to cephalosporins and amikacin significantly increased, while, the ones of piperacillintazobactam, cotrimoxazole and gentamicin had significantly decreased. Nevertheless, the ICU isolates showed an inverse scenario for cephalosporins. These findings agree with an increase of ESBLs on the Medicine (56% to 66%; p<0.0001) and on the Surgery (54% to 62%; p=0.0197) departments, with a parallel decrease in the ICU (76% to 68%). In summary, high levels of antimicrobial resistance have been reported among E. coli, with worrisome levels of ESBL. A continuous surveillance of antimicrobial resistance levels in the area is needed. KEY WORDS: Escherichia coli; antimicrobial resistance; cephalosporins
- 4 October 2022
- Published by Universidade Federal de Goias in Revista de Patologia Tropical / Journal of Tropical Pathology
- Vol. 51 (3) , 197-212
Open AccessEvolution of the prevalence and antimicrobial resistance among Escherichia coli isolated as a cause of infection in patients admitted to a iv-level hospital in Lima, Peru
The levels and evolution of antimicrobial resistance of Escherichia coli during 01/2009-06/2010 (Period 1), 01/2012-06-2013 (Period 2) and 07/2013-12/2014 (Period 3) were analyzed. Identification, susceptibility levels to 13 antibiotics and the presence of extendedspectrum β-lactamases (ESBLs) were determined. Overall, 9,918 microorganisms were isolated as a cause of infection. Of these 3,016 (30.4%) were E. coli, with 1,770 (59%), 992 (33%) and 254 (8%), from the Medicine and the Surgery Departments and the Intensive Care Unit (ICU), respectively. There was a significant increase (p=0.0002) of E. coli throughout considered periods. The isolates presented high levels of resistance (>60%) to cephalosporins, ciprofloxacin and cotrimoxazole, being only susceptible to imipenem (0.3% of resistance) and tigecycline. Overall the analysis of evolution of antimicrobial resistance showed that resistance to cephalosporins and amikacin significantly increased, while, the ones of piperacillintazobactam, cotrimoxazole and gentamicin had significantly decreased. Nevertheless, the ICU isolates showed an inverse scenario for cephalosporins. These findings agree with an increase of ESBLs on the Medicine (56% to 66%; p<0.0001) and on the Surgery (54% to 62%; p=0.0197) departments, with a parallel decrease in the ICU (76% to 68%). In summary, high levels of antimicrobial resistance have been reported among E. coli, with worrisome levels of ESBL. A continuous surveillance of antimicrobial resistance levels in the area is needed. KEY WORDS: Escherichia coli; antimicrobial resistance; cephalosporins
- 5 January 2022
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 116 (7) , 676-678
Worrying levels of antimicrobial resistance in Gram-negative bacteria isolated from cell phones and uniforms of Peruvian intensive care unit workers
Healthcare worker (HCW) uniforms and cell phones are involved in pathogen transmission. This study aimed to characterize pathogenic microorganism isolates from HCW uniforms and cell phones. Gram-negative microorganisms were recovered from HCW uniforms and cell phones. Antimicrobial susceptibility and the presence of extended-spectrum β-lactamases (ESBL) and carbapenemases were determined. Escherichia coli was the most prevalent microorganism. Overall, high levels of resistance to cephalosporins, quinolones, co-trimoxazole and colistin were found. ESBL were mainly related to blaCTX-M-15 and blaSHV- genes. Carbapenem-resistant isolates presented as blaKPC or blaNDM. High levels of antimicrobial resistance, including colistin, were detected. Therefore, strategies are urgently needed to prevent bacterial dissemination.
- 5 January 2022
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 116 (7) , 676-678
Worrying levels of antimicrobial resistance in Gram-negative bacteria isolated from cell phones and uniforms of Peruvian intensive care unit workers
Healthcare worker (HCW) uniforms and cell phones are involved in pathogen transmission. This study aimed to characterize pathogenic microorganism isolates from HCW uniforms and cell phones. Gram-negative microorganisms were recovered from HCW uniforms and cell phones. Antimicrobial susceptibility and the presence of extended-spectrum β-lactamases (ESBL) and carbapenemases were determined. Escherichia coli was the most prevalent microorganism. Overall, high levels of resistance to cephalosporins, quinolones, co-trimoxazole and colistin were found. ESBL were mainly related to blaCTX-M-15 and blaSHV- genes. Carbapenem-resistant isolates presented as blaKPC or blaNDM. High levels of antimicrobial resistance, including colistin, were detected. Therefore, strategies are urgently needed to prevent bacterial dissemination.
- 2 January 2021
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 115 (1) , 53-60
Tolerance to disinfectants (chlorhexidine and isopropanol) and its association with antibiotic resistance in clinically-relatedKlebsiella pneumoniaeisolates
Disinfectants play an essential role in controlling the dissemination of bacteria in health care settings, but it may also contribute to the selection of antibiotic resistance bacteria. This study looked at Klebsiella pneumoniae isolates collected from three hospitals in Lima, Peru, in order to evaluate: their susceptibility to chlorhexidine [CHG] and isopropanol [ISP]), and their association with antimicrobial susceptibility. We analyzed 59 K. pneumoniae isolates and assessed their CHG and ISP susceptibility by minimum inhibitory concentrations (MICs). Additionally, we performed a regression analysis to assess the association between disinfectant tolerance and antibiotic resistance (measured by the disc diffusion method), colistin resistance (by microdilution), carbapenemases presence (by polymerase chain reaction [PCR]), and clonal relationships (by pulsed-field gel electrophoresis [PFGE]). Eleven K. pneumoniae strains were isolated from fomites, and 48 strains from clinical samples. The MIC range of these isolates was 8–128 µg/ml for CHG and 16–256 mg/ml for ISP. We found that resistance to trimethoprim/sulfamethoxazole (TMP/SMX) was the main factor associated with CHG log2 MIC (ß = 0.65; 95%CI: 0.03, 1.27; R2 = 0.07). In the case of ISP, the log2(MIC) was associated with the institution of origin, showing lower ISP log2(MIC) in fomites compared to clinical samples(ß = −0.77; 95%CI: −1.54, −0.01; R2 = 0.08). Resistance to CHG and ISP among K. pneumoniae isolates found in Peruvian hospitals seems to be elevated and highly variable. Further studies are needed to confirm our results and implement actionable interventions if necessary.
- 2 January 2021
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 115 (1) , 53-60
Tolerance to disinfectants (chlorhexidine and isopropanol) and its association with antibiotic resistance in clinically-relatedKlebsiella pneumoniaeisolates
Disinfectants play an essential role in controlling the dissemination of bacteria in health care settings, but it may also contribute to the selection of antibiotic resistance bacteria. This study looked at Klebsiella pneumoniae isolates collected from three hospitals in Lima, Peru, in order to evaluate: their susceptibility to chlorhexidine [CHG] and isopropanol [ISP]), and their association with antimicrobial susceptibility. We analyzed 59 K. pneumoniae isolates and assessed their CHG and ISP susceptibility by minimum inhibitory concentrations (MICs). Additionally, we performed a regression analysis to assess the association between disinfectant tolerance and antibiotic resistance (measured by the disc diffusion method), colistin resistance (by microdilution), carbapenemases presence (by polymerase chain reaction [PCR]), and clonal relationships (by pulsed-field gel electrophoresis [PFGE]). Eleven K. pneumoniae strains were isolated from fomites, and 48 strains from clinical samples. The MIC range of these isolates was 8–128 µg/ml for CHG and 16–256 mg/ml for ISP. We found that resistance to trimethoprim/sulfamethoxazole (TMP/SMX) was the main factor associated with CHG log2 MIC (ß = 0.65; 95%CI: 0.03, 1.27; R2 = 0.07). In the case of ISP, the log2(MIC) was associated with the institution of origin, showing lower ISP log2(MIC) in fomites compared to clinical samples(ß = −0.77; 95%CI: −1.54, −0.01; R2 = 0.08). Resistance to CHG and ISP among K. pneumoniae isolates found in Peruvian hospitals seems to be elevated and highly variable. Further studies are needed to confirm our results and implement actionable interventions if necessary.
- Open Access
- 1 January 2021
- Published by XMLink in Infection & Chemotherapy
- Vol. 53 (3) , 449-462
Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital
Flores-Paredes W, et al. Infect Chemother. 2021 Sep;53(3):449-462. https://doi.org/10.3947/ic.2021.0015
- 1 January 2021
- Published by XMLink in Infection & Chemotherapy
- Vol. 53 (3) , 449-462
Open AccessEvolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital
Flores-Paredes W, et al. Infect Chemother. 2021 Sep;53(3):449-462. https://doi.org/10.3947/ic.2021.0015
- 10 November 2018
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 122 (2) , 269-276
Recruitment manoeuvres dislodge mucus towards the distal airways in an experimental model of severe pneumonia
- 10 November 2018
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 122 (2) , 269-276
Recruitment manoeuvres dislodge mucus towards the distal airways in an experimental model of severe pneumonia